Search Results - "Filetti, Marco"

Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature.

Authors: Filetti, Marco Occhipinti, Mario Cirillo, Alessio et al.

Source: Cancers. Dec2024, Vol. 16 Issue 23, p3955. 15p.

Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings.

Authors: Lombardi, Pasquale Filetti, Marco Falcone, Rosa et al.

Source: Cancers. Mar2023, Vol. 15 Issue 6, p1744. 18p.

Motivational intensity and visual word search: Layout matters.

Authors: Filetti, Marco Barral, Oswald Jacucci, Giulio et al.

Source: PLoS ONE. 7/23/2019, Vol. 14 Issue 7, p1-36. 36p.

Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey.

Authors: Filetti, Marco Trapani, Dario Cortellini, Alessio et al.

Source: Supportive Care in Cancer. Dec2021, Vol. 29 Issue 12, p7845-7854. 10p.

Countering Countermeasures: Detecting Identity Lies by Detecting Conscious Breakthrough.

Authors: Bowman, Howard Filetti, Marco Alsufyani, Abdulmajeed et al.

Source: PLoS ONE. Mar2014, Vol. 9 Issue 3, p1-17. 17p.

Subliminal Salience Search Illustrated: EEG Identity and Deception Detection on the Fringe of Awareness.

Authors: Bowman, Howard Filetti, Marco Janssen, Dirk et al.

Source: PLoS ONE. Jan2013, Vol. 8 Issue 1, Special section p1-21. 21p.

Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients.

Authors: Falcone, Rosa Lombardi, Pasquale Filetti, Marco et al.

Source: Current Oncology. Feb2023, Vol. 30 Issue 2, p2501-2509. 9p. 2 Charts, 1 Graph.

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.

Authors: Cortellini, Alessio Giusti, Raffaele Filetti, Marco et al.

Source: Journal of Hematology & Oncology. 1/21/2022, Vol. 15 Issue 1, p1-6. 6p.

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs.

Authors: Filetti, Marco Marchetti, Paolo Capalbo, Carlo et al.

Source: International Journal of Molecular Sciences. Apr2019, Vol. 20 Issue 7, p1607-1607. 1p. 1 Color Photograph, 1 Chart, 1 Graph.

Breakthrough percepts of famous faces.

Authors: Alsufyani, Abdulmajeed Hajilou, Omid Zoumpoulaki, Alexia et al.

Source: Psychophysiology. Jan2019, Vol. 56 Issue 1, pN.PAG-N.PAG. 1p. 1 Diagram, 6 Charts, 6 Graphs.

Subjects: Face perception, Brain, Celebrities, Visual perception, Central nervous system

Attention is more than prediction precision.

Authors: Bowman, Howard Filetti, Marco Wyble, Brad et al.

Source: Behavioral & Brain Sciences. Jun2013, Vol. 36 Issue 3, p206-208. 3p.

Subjects: Attention, Prediction models, Coding theory, Evoked potentials (Electrophysiology), Stimulus & response (Biology), Sensory neurons, Brain mapping

The cost of space independence in P300-BCI spellers.

Authors: Chennu, Srivas Alsufyani, Abdulmajeed Filetti, Marco et al.

Source: Journal of NeuroEngineering & Rehabilitation (JNER). 2013, Vol. 10 Issue 1, p1-13. 13p. 1 Black and White Photograph, 4 Charts, 5 Graphs.

Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival

Authors: Choucair, Khalil Nebhan, Caroline Cortellini, Alessio et al.

Source: Cancers. Oct2023, Vol. 15 Issue 20, p5052. 12p.

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023).

Authors: Iannantuono, Giovanni Maria Floudas, Charalampos S. Filetti, Marco et al.

Source: European Journal of Cancer. Jul2025, Vol. 225, pN.PAG-N.PAG. 1p.

Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years.

Authors: Falcone, Rosa Lombardi, Pasquale Filetti, Marco et al.

Source: Cancers. Feb2022, Vol. 14 Issue 4, p889. 1p.

Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials.

Authors: Duranti, Simona Fabi, Alessandra Filetti, Marco et al.

Source: Cancers. Oct2021, Vol. 13 Issue 20, p5198. 1p.

Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.

Authors: Giusti, Raffaele Mazzotta, Marco Filetti, Marco et al.

Source: Supportive Care in Cancer. Sep2019, Vol. 27 Issue 9, p3531-3535. 5p.

Exploring subliminal salience using the P-300 : applications to identity deception

Authors: Filetti, Marco

URL: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.655649

PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.

Authors: Santini, Daniele Zeppola, Tea Russano, Marco et al.

Source: Journal of Translational Medicine. 6/24/2021, Vol. 19 Issue 1, p1-8. 8p.

CT based radiomic approach on first line pembrolizumab in lung cancer.

Authors: Zerunian, Marta Caruso, Damiano Zucchelli, Alberto et al.

Source: Scientific Reports. 3/23/2021, Vol. 11 Issue 1, p1-10. 10p.